Marlin Equity Partners has completed a majority growth investment in Radar Healthcare, aimed at enhancing its product development and supporting international expansion in the healthcare software market.
Information on the Target
Radar Healthcare, a leading provider of risk, quality, and compliance software, is dedicated to enhancing healthcare and social care services. The Company supports over 250 participants globally, focusing on patient safety and care excellence. Its comprehensive suite of solutions aims to foster improved care outcomes while addressing the challenges faced by healthcare providers.
By integrating digital innovation with healthcare expertise, Radar Healthcare creates systems that not only comply with regulatory standards but also enhance operational efficiency. The partnership with Marlin Equity Partners is anticipated to further strengthen Radar’s market presence and accelerate product development and international expansion.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare and social care sectors have witnessed significant growth and transformation in recent years, driven by technological advancements and increasing demand for integrated care solutions. I
Similar Deals
Growth Lending → A & R Care Limited
2025
Foresight Group → Functional Gut Group
2025
NorthEdge → RoukenBio
2024
Fort Aggregator LP and The Prudential Assurance Company Limited → 4basebio PLC
2024
N4 Partners → NeuroClin
2024
Rockpool → TalarMade
2024
Marlin Equity Partners
invested in
Radar Healthcare
in 2024
in a Growth Equity & Expansion Capital deal